BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 30672017)

  • 1. Assessing the severity of Type 2 diabetes using clinical data-based measures: a systematic review.
    Zghebi SS; Panagioti M; Rutter MK; Ashcroft DM; van Marwijk H; Salisbury C; Chew-Graham CA; Buchan I; Qureshi N; Peek N; Mallen C; Mamas M; Kontopantelis E
    Diabet Med; 2019 Jun; 36(6):688-701. PubMed ID: 30672017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth.
    Zeitler P; Arslanian S; Fu J; Pinhas-Hamiel O; Reinehr T; Tandon N; Urakami T; Wong J; Maahs DM
    Pediatr Diabetes; 2018 Oct; 19 Suppl 27():28-46. PubMed ID: 29999228
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redesigning Primary Care to Improve Diabetes Outcomes (the UNITED Study).
    Peterson KA; Carlin C; Solberg LI; Jacobsen R; Kriel T; Eder M
    Diabetes Care; 2020 Mar; 43(3):549-555. PubMed ID: 31882407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents.
    Mayer-Davis EJ; Kahkoska AR; Jefferies C; Dabelea D; Balde N; Gong CX; Aschner P; Craig ME
    Pediatr Diabetes; 2018 Oct; 19 Suppl 27(Suppl 27):7-19. PubMed ID: 30226024
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors influencing safe glucose-lowering in older adults with type 2 diabetes: A PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people: A position statement of Primary Care Diabetes Europe.
    Hambling CE; Khunti K; Cos X; Wens J; Martinez L; Topsever P; Del Prato S; Sinclair A; Schernthaner G; Rutten G; Seidu S
    Prim Care Diabetes; 2019 Aug; 13(4):330-352. PubMed ID: 30792156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome in pediatrics: do we have a reliable definition? A systematic review.
    Tropeano A; Corica D; Li Pomi A; Pepe G; Morabito LA; Curatola SL; Casto C; Aversa T; Wasniewska M
    Eur J Endocrinol; 2021 Jul; 185(2):265-278. PubMed ID: 34061767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
    Hofer TP; Hayward RA; Greenfield S; Wagner EH; Kaplan SH; Manning WG
    JAMA; 1999 Jun; 281(22):2098-105. PubMed ID: 10367820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How diabetes risk assessment tools are implemented in practice: a systematic review.
    Dhippayom T; Chaiyakunapruk N; Krass I
    Diabetes Res Clin Pract; 2014 Jun; 104(3):329-42. PubMed ID: 24485859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal-bolus insulin versus sliding-scale insulin for inpatient glycaemic control: a clinical practice comparison.
    Roberts GW; Aguilar-Loza N; Esterman A; Burt MG; Stranks SN
    Med J Aust; 2012 Mar; 196(4):266-9. PubMed ID: 22409694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the definition of osteoarthritis and of the timing of its onset on the association between type 2 diabetes mellitus and osteoarthritis: Clinical Practice Research Datalink.
    Nielen JTH; Dagnelie PC; Boonen A; Klungel O; van den Bemt B; de Vries F
    Diabetes Res Clin Pract; 2019 Feb; 148():240-248. PubMed ID: 30685347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intensive interventions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials.
    Usman M; Gillies CL; Khunti K; Davies MJ
    Diabetes Res Clin Pract; 2018 Dec; 146():76-84. PubMed ID: 30312714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Complications Severity Index (DCSI)-Update and ICD-10 translation.
    Glasheen WP; Renda A; Dong Y
    J Diabetes Complications; 2017 Jun; 31(6):1007-1013. PubMed ID: 28416120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in diabetes management of nursing home patients based on functional and cognitive status.
    McNabney MK; Pandya N; Iwuagwu C; Patel M; Katz P; James V; Calabrese B; Lawhorne L
    J Am Med Dir Assoc; 2005; 6(6):375-82. PubMed ID: 16286058
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.